a commercial-stage company, which focuses on rare diseases that transform real-world clinical and genetic data into actionable information for patients, physicians and pharmaceutical companies
Industry MedicalSpecialties
A.I.dvisor tells us that CNTGF and BBLG have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CNTGF and BBLG's prices will move in lockstep.
| Ticker / NAME | Correlation To CNTGF | 1D Price Change % | ||
|---|---|---|---|---|
| CNTGF | 100% | -16.77% | ||
| BBLG - CNTGF | 30% Poorly correlated | -7.75% | ||
| IRIX - CNTGF | 28% Poorly correlated | -4.52% | ||
| MASS - CNTGF | 26% Poorly correlated | +0.42% | ||
| POAI - CNTGF | 25% Poorly correlated | -7.23% | ||
| TMDIF - CNTGF | 24% Poorly correlated | N/A | ||
More | ||||